BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31176790)

  • 1. Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhao Y; Gao F; Shi J; Luo Y; Tan Y; Lai X; Yu J; Huang H
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1898-1907. PubMed ID: 31176790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Chang YJ; Wang YZ; Chen YH; Han W; Wang Y; Sun YQ; Yan CH; Wang FR; Liu YR; Xu LP; Liu DH; Huang XJ
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1465-73. PubMed ID: 23879970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
    Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
    Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes.
    Chen J; Pang A; Zhao Y; Liu L; Ma R; Wei J; Chen X; He Y; Yang D; Zhang R; Zhai W; Ma Q; Jiang E; Han M; Zhou J; Feng S
    Hematology; 2022 Dec; 27(1):293-299. PubMed ID: 35192779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
    Song Y; Zhao HY; Lyu ZS; Cao XN; Shi MM; Wen Q; Tang FF; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1981-1989. PubMed ID: 29933074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    López-Corral L; Caballero-Velázquez T; López-Godino O; Rosiñol L; Pérez-Vicente S; Fernandez-Avilés F; Krsnik I; Morillo D; Heras I; Morgades M; Rifon JJ; Sampol A; Iniesta F; Ocio EM; Martin J; Rovira M; Cabero M; Castilla-Llorente C; Ribera JM; Torres-Juan M; Moraleda JM; Martinez C; Vázquez A; Gutierrez G; Caballero D; San Miguel JF; Mateos MV; Pérez-Simón JA
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1703-1712. PubMed ID: 31054983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Wang YT; Cao XN; Song Y; Chen YH; Sun YQ; Wang Y; Zhang XH; Xu LP; Huang XJ
    J Transl Med; 2017 Mar; 15(1):57. PubMed ID: 28292332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
    Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children.
    Ke P; Bao X; Zhou J; Zhu Q; Zhuang J; Hu X; Liu Y; Wu D; Xue S; Zhang X; Ma X
    Acta Haematol; 2019; 142(4):217-223. PubMed ID: 31597154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.
    Balaguer-Rosello A; Bataller L; Piñana JL; Montoro J; Lorenzo I; Villalba A; Freiria C; Santiago M; Sevilla T; Muelas N; Guerreiro M; Carretero C; Gómez I; Solves P; Sanz MÁ; Sanz G; Sanz J
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1818-1824. PubMed ID: 31132454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
    Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
    Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Olsson RF; Logan BR; Chaudhury S; Zhu X; Akpek G; Bolwell BJ; Bredeson CN; Dvorak CC; Gupta V; Ho VT; Lazarus HM; Marks DI; Ringdén OT; Pasquini MC; Schriber JR; Cooke KR
    Leukemia; 2015 Aug; 29(8):1754-62. PubMed ID: 25772027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia].
    Shi CY; Mamal ZH; Liu XX; Wu LH; Xia DN; Nie YR; Lai FQ; Duan HW; Xiao ZJ; Jiang YH; Li Y; Xiao Y
    Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):761-766. PubMed ID: 29081192
    [No Abstract]   [Full Text] [Related]  

  • 19. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
    Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
    Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.